Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Dec 17, 2025 · Filed Dec 18, 2025
A board member of Hims & Hers Health sold $259K of Hims & Hers Health shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$258,952
Shares × reported transaction price
44 days after results of Nov 3, 2025, 68 days before results of Feb 23, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −3.5% | +1.4% | −5.0% |
| 30 days | −14.3% | −0.4% | −13.9% |
| 90 days | −32.1% | −3.0% | −29.0% |
| 180 days | −10.3% | +8.9% | −19.2% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
CFO sold ~$306K of Hims & Hers Health
Scheduled in advance